- Home
- TANH vs CNSP Comparison
TANH vs CNSP Comparison
Compare TANH & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TANH | CNSP |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 8.5M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TANH | CNSP |
|---|---|---|
| Price | $12.51 | $3.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 124.8K | 16.9K |
| Earning Date | 12-18-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.17 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $1.90 |
| 52 Week High | $29.89 | $10.54 |
Technical Indicators
Market Signals| Indicator | TANH | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 48.27 | 34.89 |
| Support Level | $12.62 | $2.01 |
| Resistance Level | $18.29 | $4.00 |
| Average True Range (ATR) | 4.12 | 0.64 |
| MACD | -0.18 | -0.09 |
| Stochastic Oscillator | 24.16 | 12.57 |
Price Performance
Historical ComparisonAbout TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.